Life or death? Autophagy in anticancer therapies with statins and histone deacetylase inhibitors

Pei Ming Yang, Ching Chow Chen

Research output: Contribution to journalReview article

16 Citations (Scopus)

Abstract

Autophagy, which could be either cytoprotective or cytotoxic, is often observed in tumor cells in response to chemotherapy. Understanding the signaling pathways involved in the regulation of autophagy represents a new direction in the development of anticancer therapies. Our recent studies investigate the role of autophagy in the anticancer effects of statins and histone deacetylase inhibitors (HDACi). Inhibition of autophagy enhances the efficacy of statins, whereas autophagic cell death in cancer cells is induced by HDACi. Here, we will discuss the differential signaling pathways elicited by statins and HDACi. We find that AMPK, cytoplasmic p21 and Akt signaling are crucial determinants of cell fates (i.e., life or death) while autophagy is induced.

Original languageEnglish
Pages (from-to)107-108
Number of pages2
JournalAutophagy
Volume7
Issue number1
DOIs
Publication statusPublished - Jan 2011
Externally publishedYes

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Histone Deacetylase Inhibitors
Autophagy
Therapeutics
AMP-Activated Protein Kinases
Neoplasms
Drug Therapy

Keywords

  • Akt
  • AMPK
  • Apoptosis
  • Autophagy
  • Cytoplasmic p21
  • ER stress
  • Histone deacetylase
  • Statins

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

Life or death? Autophagy in anticancer therapies with statins and histone deacetylase inhibitors. / Yang, Pei Ming; Chen, Ching Chow.

In: Autophagy, Vol. 7, No. 1, 01.2011, p. 107-108.

Research output: Contribution to journalReview article

@article{64b9d9f1812a40f980e9a7215118efa8,
title = "Life or death? Autophagy in anticancer therapies with statins and histone deacetylase inhibitors",
abstract = "Autophagy, which could be either cytoprotective or cytotoxic, is often observed in tumor cells in response to chemotherapy. Understanding the signaling pathways involved in the regulation of autophagy represents a new direction in the development of anticancer therapies. Our recent studies investigate the role of autophagy in the anticancer effects of statins and histone deacetylase inhibitors (HDACi). Inhibition of autophagy enhances the efficacy of statins, whereas autophagic cell death in cancer cells is induced by HDACi. Here, we will discuss the differential signaling pathways elicited by statins and HDACi. We find that AMPK, cytoplasmic p21 and Akt signaling are crucial determinants of cell fates (i.e., life or death) while autophagy is induced.",
keywords = "Akt, AMPK, Apoptosis, Autophagy, Cytoplasmic p21, ER stress, Histone deacetylase, Statins",
author = "Yang, {Pei Ming} and Chen, {Ching Chow}",
year = "2011",
month = "1",
doi = "10.4161/auto.7.1.13988",
language = "English",
volume = "7",
pages = "107--108",
journal = "Autophagy",
issn = "1554-8627",
publisher = "Landes Bioscience",
number = "1",

}

TY - JOUR

T1 - Life or death? Autophagy in anticancer therapies with statins and histone deacetylase inhibitors

AU - Yang, Pei Ming

AU - Chen, Ching Chow

PY - 2011/1

Y1 - 2011/1

N2 - Autophagy, which could be either cytoprotective or cytotoxic, is often observed in tumor cells in response to chemotherapy. Understanding the signaling pathways involved in the regulation of autophagy represents a new direction in the development of anticancer therapies. Our recent studies investigate the role of autophagy in the anticancer effects of statins and histone deacetylase inhibitors (HDACi). Inhibition of autophagy enhances the efficacy of statins, whereas autophagic cell death in cancer cells is induced by HDACi. Here, we will discuss the differential signaling pathways elicited by statins and HDACi. We find that AMPK, cytoplasmic p21 and Akt signaling are crucial determinants of cell fates (i.e., life or death) while autophagy is induced.

AB - Autophagy, which could be either cytoprotective or cytotoxic, is often observed in tumor cells in response to chemotherapy. Understanding the signaling pathways involved in the regulation of autophagy represents a new direction in the development of anticancer therapies. Our recent studies investigate the role of autophagy in the anticancer effects of statins and histone deacetylase inhibitors (HDACi). Inhibition of autophagy enhances the efficacy of statins, whereas autophagic cell death in cancer cells is induced by HDACi. Here, we will discuss the differential signaling pathways elicited by statins and HDACi. We find that AMPK, cytoplasmic p21 and Akt signaling are crucial determinants of cell fates (i.e., life or death) while autophagy is induced.

KW - Akt

KW - AMPK

KW - Apoptosis

KW - Autophagy

KW - Cytoplasmic p21

KW - ER stress

KW - Histone deacetylase

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=78650836614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650836614&partnerID=8YFLogxK

U2 - 10.4161/auto.7.1.13988

DO - 10.4161/auto.7.1.13988

M3 - Review article

C2 - 21057221

AN - SCOPUS:78650836614

VL - 7

SP - 107

EP - 108

JO - Autophagy

JF - Autophagy

SN - 1554-8627

IS - 1

ER -